Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

IPO Update: 28 Biopharma Companies Raise $3bn, Provide An Average 10% Return

Jun 28 2019

• By Mandy Jackson

Closed up finger on keyboard with word IPO — 28 biopharma companies have raised $3bn in US IPOs this year. • Source: Shutterstock

Related Content

AbbVie Buys In On Morphic’s Oral Integrin Inhibitors, To Tune Of $100m

Oct 18 2018

The Next Roivant Or Fortress? BridgeBio Raises $135m To Spin Out New Companies

Sep 18 2017

Finance Watch: Morphic's 'Smooth' Progress With Oral Integrin Inhibitors Justifies $80m Series B

Sep 26 2018

Finance Watch: Three New Funds, Including Former Amgen R&D Head Harper's Next Venture

Sep 07 2018

BridgeBio’s $299m Gives It Two More Years Of Runway To Launch New Companies

Jan 24 2019

PureTech’s Karuna Gets Another $68m For Re-engineered Lilly CNS Candidate

Mar 19 2019

Related Companies

BridgeBio Pharma, Inc.

Quince Therapeutics, Inc.

Morphic Therapeutic, Inc.

AbbVie Inc.

Karuna Therapeutics, Inc.

Fulcrum Therapeutics Inc.

Mirum Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

Lumena Pharmaceuticals

Additional Topics

Financing Business Strategies Growth Innovation StartUps and SMEs Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window